In the video of PR added by Eire2021 on 4/02/2021 where PR talks about the IND and the P3 trials starting in Q1 2021 and completing in Q1 2023, will we have to wait for all the results to be published in Q1 2023 or will the results be progressively published during the trial.
If the results are successful then the progressive publishing of results during the trial may lead to a steady and reassuring rise in the share price which to me is better than having to wait until the end of the trial.
PAR CEO explains SAS patient results in interview, page-11
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25008 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 34768 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |